Teacher Insights: Know about how to choose the best MPPSC coaching institute  |  National Edu News: Swinburne University of Technology & IIT H launch the joint doctoral program  |  Policy Indications: India & Japan collaborations for innovations on Hydrogen based technologies  |  National Edu News: Education Minister addresses at the Annual Convocation of IIM Rohtak  |  Education Information: UPSC postpones tests and Interviews of some examinations  |  National Edu News: Piyush Goyal launches the Startup India Seed Fund Scheme  |  Teacher Insights: Are you Proficient in English?  |  National Edu News: National climate vulnerability assessment sees 8 states as highly vulnerable  |  National Edu News: Education minister e-launches long-lasting hygiene product DuroKea Series  |  National Edu News: Punjab’s new nutrient rich crop varieties can satisfy India's nutritional needs   |  Guest Column: Delicious Dhabas  |  International Edu News: 2D Perovskites for Solar Cells and LEDS  |  International Edu News: AI Model for Predicting Tsunami  |  International Edu News: Wearable Sweat Sensors on a Bandage  |  International Edu News: Smallest High Resolution Microscope  |  
April 23, 2020 Thursday 03:57:35 PM IST

First Artificial Pancreas App

International Edu News

The University of Cambridge has developed the world's first downloadable artificial pancreas app for people with type 1 diabetes. The CamAPS FX app works with an insulin pump and a glucose monitor to automatically deliver insulin to people living with the condition via a complex algorithm. The app was developed based on over a decade of research by Professor Roman Hovorka.It will be useful in patients who experience potentially dangerous low blood glucose levels at night. The app can also upload the user’s blood glucose measurements seamlessly to Diasend, an online platform, allowing their diabetes team to provide more personalised care.The app is now available for UK users to download onto Android phones via the Amazon Appstore. The app is available on a subscription basis starting at £70 per month.It is licensed for use by both adults and children with the condition and is the first artificial pancreas system to be licensed for use in pregnancy, or by young children aged one and above.

Comments